同仁堂集团致歉

Core Viewpoint - Tongrentang Group issued an apology regarding the controversy over "Antarctic krill oil," acknowledging consumer rights damage and committing to a zero-tolerance brand management initiative [1] Group 1: Company Actions - The company has initiated a special task force to conduct a thorough investigation of the implicated products in Sichuan, ensuring a comprehensive inquiry [1] - The company has ordered the immediate removal of the implicated products from the market and will supervise compliance with regulatory requirements for consumer compensation [1] - Legal actions will be pursued against Sichuan Health, Habao Pharmaceutical, and related e-commerce platforms for trademark infringement and misleading practices [1] Group 2: Product Investigation - The Shanghai Consumer Protection Commission tested 15 popular Antarctic krill oil products, revealing that one product labeled as "Beijing Tongrentang 99% High Purity Antarctic Krill Oil" had a phospholipid content of 0, indicating potential fraud [4] - The implicated product was not directly produced by Beijing Tongrentang but was distributed by its subsidiary, Sichuan Health Pharmaceutical, with production outsourced to Anhui Habao Pharmaceutical, representing a typical private label model [7] Group 3: Brand Management Issues - The product in question was produced without authorization to prominently feature the "Beijing Tongrentang" name, leading to legal proceedings initiated by the company against the involved entities [7] - Beijing Tongrentang, the sole legal holder of the "Tongrentang" trademark, has faced trust issues due to repeated incidents of private label mismanagement, raising concerns about brand authorization and quality control [7]